<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02467257</url>
  </required_header>
  <id_info>
    <org_study_id>AlNeelainU</org_study_id>
    <nct_id>NCT02467257</nct_id>
  </id_info>
  <brief_title>Gum Arabic as Fetal Hemoglobin Agent in Sickle Cell Anemia</brief_title>
  <official_title>Potential Role of Gum Arabic as Fetal Hemoglobin Agent in Sudanese Sickle Cell Anemia Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Al-Neelain University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Military hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Higher Education and Scientific Research, Republic of Sudan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Al-Neelain University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Gum Arabic is effective as fetal hemoglobin
      inducing agent for sickle cell anemia patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      : High level of fetal haemoglobin (Hb F) decreases sickle cell anaemia (SCA) severity and
      leads to improved survival. Butyrate proved to increase HbF production in vivo and in vitro
      studies. Nonetheless, its short half-life limited its utilization in clinical practice. Gum
      Arabic (GA) is edible, dried, gummy exudate from Acacia Senegal tree. GA fermentation by
      colonic bacteria increases serum butyrate concentrations. The investigators hypothesized
      regular intake of GA will increase serum butyrate level. The latter will induce fetal
      hemoglobin production and ameliorate patients' symptoms. 47 patients hemoglobin SS aged 5-42
      years, on regular follow up in Military hospital were recruited from April 2014 to January
      2015 Patients received dose of G A 30g/day for 12 weeks. Hb F, complete blood count and
      Erythropoietin level were measured. The main outcome of interest was the level of HbF after
      12 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary endpoint of the study will be the level of fetal hemoglobin after three months</measure>
    <time_frame>12 weeks</time_frame>
    <description>fetal hemoglobin will be measured each month for three months</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">47</enrollment>
  <condition>Sickle Cell Anemia</condition>
  <arm_group>
    <arm_group_label>Intrevention arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients received Gum Arabic as intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Gum Arabic</intervention_name>
    <description>oral ingestion of 30 gram every day for 12 weeks</description>
    <arm_group_label>Intrevention arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. over 5 year old

          2. less t5han 50

          3. diagnosed with homozygous sickle cell anemia by Hb electrophoresis

        Exclusion Criteria:

        1. patients received blood transfusion within the last three months or admitted to the
        hospital within 2 weeks because of Sickle cell anemia -related events or crisis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amal M Saeed, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Khartoum Faculty of Medicine Department of Physiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lamis AA Kaddam, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of physiology Faculty of Medicine Alneelain University Khartoum,</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Military Hospital</name>
      <address>
        <city>Omdurman</city>
        <state>Khartoum</state>
        <zip>1113</zip>
        <country>Sudan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sudan</country>
  </location_countries>
  <reference>
    <citation>Fathallah H, Atweh GF. Induction of fetal hemoglobin in the treatment of sickle cell disease. Hematology Am Soc Hematol Educ Program. 2006:58-62. Review.</citation>
    <PMID>17124041</PMID>
  </reference>
  <reference>
    <citation>Kutlar A, Reid ME, Inati A, Taher AT, Abboud MR, El-Beshlawy A, Buchanan GR, Smith H, Ataga KI, Perrine SP, Ghalie RG. A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2013 Nov;88(11):E255-60. doi: 10.1002/ajh.23533. Epub 2013 Oct 3.</citation>
    <PMID>23828223</PMID>
  </reference>
  <reference>
    <citation>Matsumoto N, Riley S, Fraser D, Al-Assaf S, Ishimura E, Wolever T, Phillips GO, Phillips AO. Butyrate modulates TGF-beta1 generation and function: potential renal benefit for Acacia(sen) SUPERGUM (gum arabic)? Kidney Int. 2006 Jan;69(2):257-65.</citation>
    <PMID>16408114</PMID>
  </reference>
  <reference>
    <citation>Ballal A, Bobbala D, Qadri SM, FÃ¶ller M, Kempe D, Nasir O, Saeed A, Lang F. Anti-malarial effect of gum arabic. Malar J. 2011 May 20;10:139. doi: 10.1186/1475-2875-10-139.</citation>
    <PMID>21599958</PMID>
  </reference>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 4, 2015</study_first_submitted>
  <study_first_submitted_qc>June 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2015</study_first_posted>
  <last_update_submitted>June 5, 2015</last_update_submitted>
  <last_update_submitted_qc>June 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Al-Neelain University</investigator_affiliation>
    <investigator_full_name>Lamis Kaddam</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Anemia, Sickle Cell</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>January 26, 2017</submitted>
    <returned>March 15, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

